Sign inJoin waitlistJoin the waitlist

Han Koh

Section Chief · Loma Linda University Health Education Consortium

Credentials: · · · · ·

History

Hematology and Medical Oncology
1993–1996
Internal Medicine
1990–1993
Saint Louis University School of Medicine
1986–1990

Research

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
Journal of Clinical Oncology · 2017 · 1,358 citations
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
The Lancet · 2011 · 883 citations
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A…
JAMA Oncology · 2020 · 818 citations

George Sledge
3 papers
Peter Kaufman
3 papers
FG
Francis Giles
2 papers
Solomon Hamburg
2 papers
SL
Stephen Lim
2 papers
AM
Abdul Hai Mansoor
1 paper
Adedayo Onitilo
1 paper
AW
Alan Waxman
1 paper
AM
Alexander Menter
1 paper
AK
Andrew Kellum
1 paper
Anneliese Gonzalez
1 paper
Annie Park
1 paper · 1 as a fellow